SAS Output

14-DEC-2018 6:10

GI ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1613-mCRC, Adv/Met, TP vs CETIRI 1 Y 0 Screening 130 106 105 71 31 7 1 11/27/2017 342 127
            106 105 71 31 7 1      
 
    2 Y 1 Trastuzumab + Pertuzumab 130 6 6 2 2 1 0 11/27/2017    
        2 Cetuximab + Irinotecan   6 6 4 1 0 0      
            12 12 6 3 1 0      
 
    3 Y 3 Crossover: Trastuz + Pertuz 130 2 2 2 0 0 0 11/27/2017    
            2 2 2 0 0 0      
 
Yes A021502-Colon, Stg III, Chemo +/- Atezol, ATOMIC 1 E Total Registrations   9 9 5 3 2 1 03/23/2018 123 47
            9 9 5 3 2 1      
 
  N1048-Rectal,LocalAdv,ChemoRT+/-FOLFOX 1 E Total Registrations   168 35 17 11 3 1 06/05/2013 372 155
            168 35 17 11 3 1      
 
No A021501-Adeno Panc,Borderline Resect,Chemo vs ChemoRT 0 E Total Registrations   18 6 0 0 0 0 05/01/2017 84 30
            18 6 0 0 0 0      
 
    1 E Total Registrations   15 5 0 0 0 0 05/01/2017    
            15 5 0 0 0 0      
 
  EA2142-GI NEC, Adv G3, EP vs TMZ + CAP 1 E Total Registrations   4 0 0 0 0 0 07/14/2016 211 88
            4 0 0 0 0 0      
 
  EA2161-PANC, Adv Rapalog Resistant PNETs, MLN0128 1 E Total Registrations   1 1 1 0 0 0 09/06/2018 27 8
            1 1 1 0 0 0      
 
  EA2165-Anal, Stg II-III, Nivolumab after CMT 1 E Total Registrations   2 2 2 2 1 0 10/09/2018 28 16
            2 2 2 2 1 0      
 
    2 E Total Registrations   1 1 1 1 1 0 10/09/2018    
            1 1 1 1 1 0      
 
  NRGGI002-Rectal, Ph II, Sensitization using TNT 1 E Total Registrations   13 9 7 7 1 0 02/21/2017 371 153
            13 9 7 7 1 0      
 
  NRGGI004-Colorectal, Stg IV, dMMR Immuno-Therapy 1 E Total Registrations   4 4 3 1 0 0 04/18/2018 121 41
            4 4 3 1 0 0      
 

14-DEC-2018 6:10

GI Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
S1815 Biliary, Met/LocAdv, GC+CPT±Nab-paclitaxel 1 Randomization 03-Dec-18